Company Description
Teladoc Health, Inc. (NYSE: TDOC) is described as the global leader in virtual care. The company focuses on delivering and orchestrating care across patients, care providers, platforms, and partners, with the goal of transforming virtual care into a catalyst for how better health happens. Through its relationships with health plans, employers, providers, health systems and consumers, Teladoc Health seeks to enable more access to care, drive better outcomes, extend provider capacity and lower costs.
According to company disclosures, Teladoc Health operates through at least two primary segments: an Integrated Care segment and the BetterHelp segment. The Integrated Care segment is referenced in the company’s financial reporting and outlook, and is associated with virtual urgent care and broader integrated virtual care offerings. The BetterHelp segment is referenced as a separate reporting segment focused on mental health services. The company’s revenue is reported by type as access fees and other revenue, and access fees are described as being generated on a subscription basis, per member, per month, with additional revenue from visit fees and equipment rental and sales to hospital systems.
Teladoc Health’s business is centered on virtual care programs that connect members with licensed care providers. The company states that it has been delivering 24/7 Care virtual visits for more than 20 years and that more than 100 million Americans have access to at least one Teladoc Health service through their health plan or employer. Its virtual urgent care service provides access to licensed care providers who assess and treat non-emergency medical needs 24 hours a day, seven days a week.
Virtual urgent care and 24/7 Care
Teladoc Health highlights a flagship virtual urgent care service, referred to as 24/7 Care, which offers access to licensed care providers for non-emergency needs at any time. The company reports that in its enhanced 24/7 Care service, care teams can address a broader set of conditions, engage specialist input when needed, support preventive care, connect patients to additional in-network care, and check prescription benefits in real time. The company states that this service is enabled by its Prism care delivery platform, which supports new clinical capabilities.
In connection with 24/7 Care, Teladoc Health reports that its care providers can treat a wider range of conditions, including back and joint pain, hair loss, sleep issues and more, and provide added support and medication optimization for members with uncontrolled hypertension, diabetes, asthma and COPD. The company also notes that when a member has a more complex health concern, Teladoc Health’s care providers can consult with a board-certified specialist during the visit to help confirm care plans and resolve health needs in a single 24/7 Care visit.
Integrated data and preventive care
Teladoc Health states that its care providers can leverage integrated claims and Health Information Exchange (HIE) data to identify gaps in care and address high-value preventive care needs during a 24/7 Care visit. Examples cited by the company include referring members to in-network providers for recommended breast, colorectal and cervical cancer screenings. The company reports that early data show a substantial portion of members agreeing to take action on preventive care recommendations made during a 24/7 Care visit.
The company also describes the ability of its care providers to connect members to other Teladoc Health services and in-person care when clinically appropriate. This includes referrals to high-value, in-network specialists or to Teladoc Health programs related to diabetes, hypertension, weight management and mental health therapy.
Prescription benefits and pharmacy insight
Teladoc Health reports that its care providers can check prescription benefits in real time, including which drugs are covered by a member’s plan, copay amounts and preferred alternatives. According to the company, this capability is intended to help people access affordable and effective medications, improve medication adherence and increase member satisfaction.
Technology platforms and partnerships
The company describes its technology as purpose-built for virtual care, referencing its Prism care delivery platform as enabling expanded clinical capabilities in the 24/7 Care service. Teladoc Health also appears in announcements describing integrations with other virtual care technology providers. For example, an integration is described between TytoCare’s Home Smart Clinic and Teladoc Health’s 24/7 Care and Primary360 primary care programs, using home diagnostic technology to provide clinical insights to virtual care clinicians. In that context, Teladoc Health’s care teams are described as being able to conduct remote physical exams using TytoCare’s handheld device, including lung, throat, ear, heart, skin and temperature assessments, and to augment chronic condition management for conditions such as asthma and hypertension.
Customer and member relationships
Teladoc Health states that it works with health plans, employers, providers, health systems and consumers. The company notes that, at its reported scale, many Americans have access to at least one Teladoc Health service through a health plan or employer. In a separate announcement regarding a third-party company, Teladoc Health is cited as leveraging an external contractor management platform to provide its healthcare providers with a payment experience described as seamless, indicating that Teladoc Health works with a large number of healthcare providers and manages payments to them.
Financial reporting and segments
In its financial results for 2025 periods, Teladoc Health reports revenue by type (access fees and other revenue) and by geography (U.S. and International). The company also reports results by segment, including Integrated Care segment revenue and BetterHelp segment revenue, and provides adjusted EBITDA metrics for each segment. The company’s SEC filings and earnings releases discuss non-GAAP financial measures such as adjusted EBITDA, along with reconciliations to net loss, and describe the use of these measures for business planning and performance evaluation.
Teladoc Health’s filings also reference capital allocation priorities, including maintaining a balance sheet profile, investing in the business through organic and inorganic initiatives, and evaluating share repurchases as a potential use of excess cash. The company has disclosed entering into a credit agreement providing for a five-year senior secured revolving credit facility, described as intended to preserve and enhance financial and operational flexibility.
Corporate governance and equity plans
SEC filings indicate that Teladoc Health has adopted a 2023 Employment Inducement Incentive Award Plan, which has been amended to increase the number of shares of common stock reserved for issuance. The plan is described as being adopted by the Board pursuant to New York Stock Exchange Rule 303A.08 without stockholder approval, and is used for employment inducement awards such as restricted stock units and performance stock units granted to new employees, including senior executives.
The company’s filings also report changes in senior leadership and Board composition, including the planned retirement of a director and the resignation of a chief financial officer to pursue another opportunity. These events are described as not resulting from disagreements with the company on matters relating to operations, policies or practices.
Stock listing and sector classification
Teladoc Health’s common stock trades on the New York Stock Exchange under the symbol TDOC. Based on the provided classification, the company operates within the health care and social assistance sector, with an industry description referencing offices of physicians (except mental health specialists). Company materials, however, describe Teladoc Health as a virtual care company that works across multiple care settings and partners, including health plans and health systems, and that operates both integrated care and mental health-focused segments.
FAQs
Stock Performance
Latest News
SEC Filings
Insider Radar
Financial Highlights
Upcoming Events
Q4 2025 earnings release
Q4 2025 results call
Earnings conference call
PSU performance period ends
Short Interest History
Short interest in Teladoc Health (TDOC) currently stands at 24.7 million shares, up 0.1% from the previous reporting period, representing 14.1% of the float. This moderate level of short interest indicates notable bearish positioning. The 6.1 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Teladoc Health (TDOC) currently stands at 6.1 days. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 257.1% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.7 to 6.1 days.